[PHARMA] YoY TTM Result on 30-Jun-2014 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-Aug-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
30-Jun-2014 [#2]
Profit Trend
QoQ- 17.85%
YoY- 39.22%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Revenue 2,234,292 2,295,554 2,113,938 2,002,411 1,846,836 1,642,700 1,492,216 6.95%
PBT 61,919 97,079 126,467 109,249 79,270 102,587 53,876 2.34%
Tax -21,162 -26,952 -26,277 -41,209 -29,878 -34,308 -17,749 2.97%
NP 40,757 70,127 100,190 68,040 49,392 68,279 36,127 2.02%
-
NP to SH 40,668 69,407 99,663 66,756 47,949 67,151 35,734 2.17%
-
Tax Rate 34.18% 27.76% 20.78% 37.72% 37.69% 33.44% 32.94% -
Total Cost 2,193,535 2,225,427 2,013,748 1,934,371 1,797,444 1,574,421 1,456,089 7.06%
-
Net Worth 542,147 524,177 528,477 502,293 480,568 481,394 451,517 3.09%
Dividend
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Div 38,883 64,750 88,011 44,519 41,172 52,948 - -
Div Payout % 95.61% 93.29% 88.31% 66.69% 85.87% 78.85% - -
Equity
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Net Worth 542,147 524,177 528,477 502,293 480,568 481,394 451,517 3.09%
NOSH 259,400 258,981 259,057 258,914 258,370 117,700 106,994 15.88%
Ratio Analysis
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
NP Margin 1.82% 3.05% 4.74% 3.40% 2.67% 4.16% 2.42% -
ROE 7.50% 13.24% 18.86% 13.29% 9.98% 13.95% 7.91% -
Per Share
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
RPS 861.33 886.38 816.01 773.39 714.80 1,395.66 1,394.66 -7.71%
EPS 15.68 26.80 38.47 25.78 18.56 57.05 33.40 -11.83%
DPS 15.00 25.00 34.00 17.20 15.94 44.99 0.00 -
NAPS 2.09 2.024 2.04 1.94 1.86 4.09 4.22 -11.04%
Adjusted Per Share Value based on latest NOSH - 258,914
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
RPS 155.03 159.28 146.68 138.94 128.14 113.98 103.54 6.95%
EPS 2.82 4.82 6.92 4.63 3.33 4.66 2.48 2.16%
DPS 2.70 4.49 6.11 3.09 2.86 3.67 0.00 -
NAPS 0.3762 0.3637 0.3667 0.3485 0.3334 0.334 0.3133 3.09%
Price Multiplier on Financial Quarter End Date
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Date 30/06/17 30/06/16 30/06/15 30/06/14 28/06/13 29/06/12 30/06/11 -
Price 4.58 5.50 7.13 4.61 4.49 10.18 5.90 -
P/RPS 0.53 0.62 0.87 0.60 0.63 0.73 0.42 3.94%
P/EPS 29.21 20.52 18.53 17.88 24.19 17.84 17.67 8.72%
EY 3.42 4.87 5.40 5.59 4.13 5.60 5.66 -8.04%
DY 3.28 4.55 4.77 3.73 3.55 4.42 0.00 -
P/NAPS 2.19 2.72 3.50 2.38 2.41 2.49 1.40 7.73%
Price Multiplier on Announcement Date
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Date 16/08/17 19/08/16 17/08/15 21/08/14 16/08/13 08/08/12 10/08/11 -
Price 4.19 5.62 5.65 4.62 4.66 8.83 5.90 -
P/RPS 0.49 0.63 0.69 0.60 0.65 0.63 0.42 2.60%
P/EPS 26.73 20.97 14.69 17.92 25.11 15.48 17.67 7.13%
EY 3.74 4.77 6.81 5.58 3.98 6.46 5.66 -6.66%
DY 3.58 4.45 6.02 3.72 3.42 5.09 0.00 -
P/NAPS 2.00 2.78 2.77 2.38 2.51 2.16 1.40 6.11%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment